Opioid Overdose

Updated: August 6, 2024

Mail Whatsapp PDF Image

Background

Opioids are class of drugs includes pain relievers, synthetic opioids, and illegal substances.

Excessive opioid consumption leads to overdose that causes severe life threating symptoms or death.

Medical professionals use short and long-acting opiates to treat poorly managed pain.

Opiates drugs approved to relieve pain for last 70 years and generally considered safe. Opioids are chemicals that bind to receptors in the brain to decrease pain signals.

Prescription opioids are authorized in the treatment of acute to chronic pain and post-surgery or injury. Use opioids only when required in cases of acute pain.

Common drugs involved in opioid overdose deaths are:

Methadone

Fentanyl

Oxycodone

Morphine

Codeine

Epidemiology

Drug enforcement agency and centers for disease control and prevention report shows a significant rise in opiate prescriptions and deaths in the United States from 2001 to 2010.

Opioid overdose has global prevalence but shows high impact in US, Canada, and Europe.

Males have more chance to die from an opioid overdose than females.

Non-Hispanic whites and American Indian natives shows the highest overdose rates. Mental health disorders also increase opioid risk.

Anatomy

Pathophysiology

Opioids target mu, delta, and kappa receptors are responsible for analgesia, dysphoria, emotional responses, and respiratory depression.

Opioid peptides bind to receptors to regulate pain and stress response. Opioids result in sedation that cause confusion and cognitive impairment.

Opioids block pain signals and change emotional pain response. Euphoria activates a reward pathway for pleasure, while sedation causes drowsiness.

Etiology

Opioids target mu, delta, and kappa receptors are responsible for analgesia, dysphoria, emotional responses, and respiratory depression.

Opioid peptides bind to receptors to regulate pain and stress response. Opioids result in sedation that cause confusion and cognitive impairment.

Opioids block pain signals and change emotional pain response. Euphoria activates a reward pathway for pleasure, while sedation causes drowsiness.

Genetics

Prognostic Factors

Early naloxone administration reverses opioid overdose effects and increases survival chances. Rapid EMS arrival and resuscitative efforts improve outcomes.

Prognosis depends on respiratory compromise severity during intervention. Severe respiratory depression can cause brain injury or death.

Younger people show better outcomes than older adults overall. Mental health impacts treatment adherence and overdose risk in prognosis.

Clinical History

Opioid overdose occurs in the highest rates between the age group of 25 to 55 years old.

Physical Examination

Neurological Examination

Gastrointestinal Examination

Respiratory Examination

Skin Examination

Age group

Associated comorbidity

Associated activity

Acuity of presentation

For Mild to Moderate Overdose:

Drowsiness, pinpoint pupils, slurred speech, confusion, and decreased respiratory rate

For Severe Overdose:

Profound respiratory depression, unconsciousness, cyanosis, bradycardia, and hypotension

Differential Diagnoses

Stroke

Intracranial Hemorrhage

Myocardial Infarction

Severe Depression

Hypoglycemia

Sepsis

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

Comatose patients in respiratory distress need immediate airway control for treatment.

Highly recommend endotracheal intubation for airway protection in patients.

Naloxone given in lowest dose in drug abuser cases to reverse respiratory apnea.

Naloxone counteracts opioids receptor, and it is administered in various routes including IV, IM, subcutaneous or intranasal.

Activated charcoal can decontaminate the gastrointestinal tract in opiate overdose patients who are alert.

Alert patients may not need airway protection, but those who are not alert need intubation first.

Effectiveness of whole bowel irrigation in opiate packet ingestion unclear due to lack of controlled studies on benefits or outcomes.
Most opiate overdose patients reversed with naloxone are observed in hospital for 12 to 24 hours.

Asymptomatic heroin overdose patients may not need 24-hour monitoring, but they require minimum 6 to 12 hours monitoring.

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

use-of-non-pharmacological-approach-for-opioid-overdose

Standardize opioid overdose protocols with naloxone and resuscitation.

Provide naloxone to at-risk individuals and their families for overdoses.

Create supervised opioid consumption sites for safer use, overdose prevention, and immediate naloxone access.

Promote policies for addiction treatment, including medication-assisted treatment and behavioural therapies.

Encourage care models for substance use and mental health to enhance outcomes for at-risk individuals.

Proper education and awareness about opioid overdose should be provided and its related causes with management strategies.

Appointments with a physician and preventing recurrence of disorder is an ongoing life-long effort.

Use of Opioid Reversal Agent

Naloxone:

It is used to reverse opioid intoxication or overdose. It reverses the effects of opioids including respiratory depression, sedation, and hypotension.

use-of-intervention-with-a-procedure-in-treating-opioid-overdose

Use bag-valve-mask ventilation if the patient is not breathing adequately or if respiratory depression persists despite naloxone administration.

Administer IV fluids if hypotension is present to improve blood pressure and circulation.

use-of-phases-in-managing-opioid-overdose

In the immediate response phase, assess consciousness level and check proper working of airway, breathing, circulation of patient.

Pharmacologic therapy is effective in the treatment phase as it includes use of naloxone drug as opioid reversal agent and some therapy intervention.

For long-acting opioids extended monitoring for up to 24 hours is needed. While for short-acting opioids monitor for minimum 4 to 6 hours post-naloxone administration.

The regular follow-up visits with the physician are scheduled to check the improvement of patients along with treatment response.

Medication

 

nalmefene 

Non–opioid-dependent patients:
0.5 mg; if further medication is required, it may be given 2 to 5 minutes later at a dose of 1 mg
It is doubtful that continuous administration of nalmefene would be effective if there is no clinical response after 1.5 mg in total
Once an adequate initial reversal has been established, stop giving nalmefene
Recurrent respiratory depression:
Patients who obtained satisfactory reversal with the initial dose regimen but continue to have respiratory depression may be given additionally nalmefene using the same dosing method as recommended for initial treatment

Opioid-dependent patients:
Initial dosage is 0.1 mg
if withdrawal symptoms are not present, increase to 0.5 mg
2 to 5 minutes later, a repeat dosage of 1 mg may be given if necessary
it is doubtful that continuous administration of nalmefene would be effective if there is no clinical response after 1.6 mg in total. Once an adequate initial reversal has been established, stop giving nalmefene.
Recurrent respiratory depression:
Patients who had recurring respiratory depression but had a sufficient response to the original dose regimen may be given more nalmefene following the same dosing schedule as recommended for initial treatment



naloxone 

Administer 0.4 to 2 mg Intravenous/Intramuscularly/Subcutaneously.
Repeat every 2 to 3min whenever necessary.
Do not exceed 10 mg.
• If the desired reaction is not obtained after providing 10 mg cumulative total, consider alternative reasons for respiratory depression.
• Endotracheal (the least acceptable delivery method, with limited anecdotal evidence): 2-2.5 times the original intravenous dosage (0.8 to 5 mg). Until minimize abrupt withdrawal, use the lowest dosages (0.1 to 0.2 mg) for chronic opioid misuse; titrate until reversal of respiratory depression.

Continuous Intravenous infusion
Alternatively, deliver two-thirds of the original effective naloxone bolus hourly (0.25-6.25 mg/hr); administer half of the initial bolus dosage 15 minutes after starting the continuous intravenous (IV) infusion to prevent naloxone levels from dropping.

Zimhi High Dose
Administer 5 mg intramuscularly or subcutaneously into the anterolateral portion of the thigh (through clothes if required); if the kid is under one year old, compress the thigh muscle while you inject the dosage.
Additional dosages may be given every 2 to 3 minutes until EMS arrives.



levallorphan 

The dose of levallorphan is based on the type and amount of opioid taken, the symptoms' severity, and the therapy response



 

naloxone 

Reversal of post-anesthesia (acute) opioid
Neonates: Administer 0.01 mg/kg intravenously into the umbilical vein, Intramuscularly or Subcutaneously; if necessary, provide a repeat dose of 0.1 mg/kg.
Children: Administer 0.1 mg/kg Intravenously given once; this dose may be repeated.

Therapeutic opioid dosage reverses respiratory depression
Dosage from the manufacturer: Administer 0.005 to 0.01 mg; repeat every 2 to 3min whenever necessary dependent on reaction.
Dosage of AAP: 0.001 to 0.015 mg/kg/dose intravenously, titrated to effect

Acute opioid overdose
≤20 kg or <5 years: Administer 0.1 mg/kg/dose
Intravenously/Intramuscularly/Subcutaneously/Endotracheally; if needed, repeat every 2 to 3min whenever necessary; Do not exceed 2 mg/dose
>20 kg or ≥ five years: Administer 2 mg Intravenously/Intramuscularly/Subcutaneously/Endotracheally; if needed, repeat every 2 to 3min whenever necessary

Zimhi High-Dose
Inject 5 mg intramuscularly or subcutaneously into the anterolateral portion of the thigh (through clothes if required); if the kid is under one year old, compress the thigh muscle while you inject the dosage.



 

Media Gallary

Content loading

Latest Posts

Opioid Overdose

Updated : August 6, 2024

Mail Whatsapp PDF Image



Opioids are class of drugs includes pain relievers, synthetic opioids, and illegal substances.

Excessive opioid consumption leads to overdose that causes severe life threating symptoms or death.

Medical professionals use short and long-acting opiates to treat poorly managed pain.

Opiates drugs approved to relieve pain for last 70 years and generally considered safe. Opioids are chemicals that bind to receptors in the brain to decrease pain signals.

Prescription opioids are authorized in the treatment of acute to chronic pain and post-surgery or injury. Use opioids only when required in cases of acute pain.

Common drugs involved in opioid overdose deaths are:

Methadone

Fentanyl

Oxycodone

Morphine

Codeine

Drug enforcement agency and centers for disease control and prevention report shows a significant rise in opiate prescriptions and deaths in the United States from 2001 to 2010.

Opioid overdose has global prevalence but shows high impact in US, Canada, and Europe.

Males have more chance to die from an opioid overdose than females.

Non-Hispanic whites and American Indian natives shows the highest overdose rates. Mental health disorders also increase opioid risk.

Opioids target mu, delta, and kappa receptors are responsible for analgesia, dysphoria, emotional responses, and respiratory depression.

Opioid peptides bind to receptors to regulate pain and stress response. Opioids result in sedation that cause confusion and cognitive impairment.

Opioids block pain signals and change emotional pain response. Euphoria activates a reward pathway for pleasure, while sedation causes drowsiness.

Opioids target mu, delta, and kappa receptors are responsible for analgesia, dysphoria, emotional responses, and respiratory depression.

Opioid peptides bind to receptors to regulate pain and stress response. Opioids result in sedation that cause confusion and cognitive impairment.

Opioids block pain signals and change emotional pain response. Euphoria activates a reward pathway for pleasure, while sedation causes drowsiness.

Early naloxone administration reverses opioid overdose effects and increases survival chances. Rapid EMS arrival and resuscitative efforts improve outcomes.

Prognosis depends on respiratory compromise severity during intervention. Severe respiratory depression can cause brain injury or death.

Younger people show better outcomes than older adults overall. Mental health impacts treatment adherence and overdose risk in prognosis.

Opioid overdose occurs in the highest rates between the age group of 25 to 55 years old.

Neurological Examination

Gastrointestinal Examination

Respiratory Examination

Skin Examination

For Mild to Moderate Overdose:

Drowsiness, pinpoint pupils, slurred speech, confusion, and decreased respiratory rate

For Severe Overdose:

Profound respiratory depression, unconsciousness, cyanosis, bradycardia, and hypotension

Stroke

Intracranial Hemorrhage

Myocardial Infarction

Severe Depression

Hypoglycemia

Sepsis

Comatose patients in respiratory distress need immediate airway control for treatment.

Highly recommend endotracheal intubation for airway protection in patients.

Naloxone given in lowest dose in drug abuser cases to reverse respiratory apnea.

Naloxone counteracts opioids receptor, and it is administered in various routes including IV, IM, subcutaneous or intranasal.

Activated charcoal can decontaminate the gastrointestinal tract in opiate overdose patients who are alert.

Alert patients may not need airway protection, but those who are not alert need intubation first.

Effectiveness of whole bowel irrigation in opiate packet ingestion unclear due to lack of controlled studies on benefits or outcomes.
Most opiate overdose patients reversed with naloxone are observed in hospital for 12 to 24 hours.

Asymptomatic heroin overdose patients may not need 24-hour monitoring, but they require minimum 6 to 12 hours monitoring.

Emergency Medicine

Endocrinology, Metabolism

Standardize opioid overdose protocols with naloxone and resuscitation.

Provide naloxone to at-risk individuals and their families for overdoses.

Create supervised opioid consumption sites for safer use, overdose prevention, and immediate naloxone access.

Promote policies for addiction treatment, including medication-assisted treatment and behavioural therapies.

Encourage care models for substance use and mental health to enhance outcomes for at-risk individuals.

Proper education and awareness about opioid overdose should be provided and its related causes with management strategies.

Appointments with a physician and preventing recurrence of disorder is an ongoing life-long effort.

Emergency Medicine

Naloxone:

It is used to reverse opioid intoxication or overdose. It reverses the effects of opioids including respiratory depression, sedation, and hypotension.

Emergency Medicine

Use bag-valve-mask ventilation if the patient is not breathing adequately or if respiratory depression persists despite naloxone administration.

Administer IV fluids if hypotension is present to improve blood pressure and circulation.

Emergency Medicine

In the immediate response phase, assess consciousness level and check proper working of airway, breathing, circulation of patient.

Pharmacologic therapy is effective in the treatment phase as it includes use of naloxone drug as opioid reversal agent and some therapy intervention.

For long-acting opioids extended monitoring for up to 24 hours is needed. While for short-acting opioids monitor for minimum 4 to 6 hours post-naloxone administration.

The regular follow-up visits with the physician are scheduled to check the improvement of patients along with treatment response.

Free CME credits

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

Digital Certificate PDF

On course completion, you will receive a full-sized presentation quality digital certificate.

medtigo Simulation

A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

medtigo Points

medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
 
  • Registration with medtigo = 10 points
  • 1 visit to medtigo’s website = 1 point
  • Interacting with medtigo posts (through comments/clinical cases etc.) = 5 points
  • Attempting a game = 1 point
  • Community Forum post/reply = 5 points

    *Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.

All Your Certificates in One Place

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.

Our Certificate Courses